- Home
- BCAX vs PMT Comparison
BCAX vs PMT Comparison
Compare BCAX & PMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCAX
- PMT
- Stock Information
- Founded
- BCAX 2018
- PMT 2009
- Country
- BCAX United States
- PMT United States
- Employees
- BCAX N/A
- PMT N/A
- Industry
- BCAX
- PMT Real Estate Investment Trusts
- Sector
- BCAX
- PMT Real Estate
- Exchange
- BCAX NYSE
- PMT Nasdaq
- Market Cap
- BCAX 1.3B
- PMT 1.2B
- IPO Year
- BCAX 2024
- PMT 2009
- Fundamental
- Price
- BCAX $20.17
- PMT $13.07
- Analyst Decision
- BCAX Strong Buy
- PMT Buy
- Analyst Count
- BCAX 4
- PMT 7
- Target Price
- BCAX $41.00
- PMT $14.93
- AVG Volume (30 Days)
- BCAX 274.3K
- PMT 843.2K
- Earning Date
- BCAX 11-12-2024
- PMT 10-22-2024
- Dividend Yield
- BCAX N/A
- PMT 12.25%
- EPS Growth
- BCAX N/A
- PMT 16.86
- EPS
- BCAX N/A
- PMT 1.41
- Revenue
- BCAX N/A
- PMT $807,048,000.00
- Revenue This Year
- BCAX N/A
- PMT N/A
- Revenue Next Year
- BCAX N/A
- PMT $24.53
- P/E Ratio
- BCAX N/A
- PMT $9.25
- Revenue Growth
- BCAX N/A
- PMT 57.27
- 52 Week Low
- BCAX $18.33
- PMT $12.81
- 52 Week High
- BCAX $28.09
- PMT $15.89
- Technical
- Relative Strength Index (RSI)
- BCAX N/A
- PMT 30.55
- Support Level
- BCAX N/A
- PMT $13.13
- Resistance Level
- BCAX N/A
- PMT $13.55
- Average True Range (ATR)
- BCAX 0.00
- PMT 0.22
- MACD
- BCAX 0.00
- PMT -0.04
- Stochastic Oscillator
- BCAX 0.00
- PMT 7.98
About BCAX BICARA THERAPEUTICS INC
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.
About PMT PennyMac Mortgage Investment Trust of Beneficial Interest
PennyMac Mortgage Investment Trust is a specialty finance company that invests primarily in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through four segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies, and corporate activities. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.